Iain Stuart - 01 Jan 2024 Form 4 Insider Report for VYNE Therapeutics Inc. (VYNE)

Role: Chief Scientific Officer
Signature: /s/ Mutya Harsch, attorney-in-fact for Iain Stuart
Issuer symbol: VYNE
Transactions as of: 01 Jan 2024
Net transactions value: -$358
Form type: 4
Filing time: 03 Jan 2024, 17:21:06 UTC
Previous filing: 15 Dec 2023
Next filing: 03 Apr 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VYNE	Common Stock	Award	$0	+62,500	+87%	$0.000000	134,055	01 Jan 2024	Direct	F1, F2
transaction	VYNE	Common Stock	Tax liability	$358	-157	-0.12%	$2.28	133,898	02 Jan 2024	Direct	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VYNE	Stock Option (right to buy)	Award	$0	+62,500		$0.000000	62,500	01 Jan 2024	Common Stock	62,500	$2.33	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Grant to the Reporting Person of a restricted stock unit ("RSU") award. Each RSU represents a contingent right to receive one share of common stock of the Issuer.
F2	The shares underlying the RSU vest over a period of 4 years. 25% of the shares subject to the award will vest on March 31, 2025 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date.
F3	Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.
F4	The shares subject to the option vest over a period of 4 years. 25% of the shares subject to the option will vest on March 31, 2025 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date.